凋亡拮抗转录因子在非酒精性脂肪性肝病与肝细胞癌发病中的调控作用
研究在小鼠NASH-HCC模型中发现凋亡拮抗转录因子(AATF)与肝细胞癌相关,并在人NASH、HCC组织及多种HCC细胞系中验证AATF过表达;TNFα经SREBP-1c诱导AATF表达,AATF与STAT3相互作用上调MCP-1,敲低AATF可抑制HCC细胞增殖、迁移、侵袭、集落形成及锚定依赖生长,并减少QGY-7703细胞在NOD scid gamma小鼠中的成瘤与转移。结论认为AATF驱动NAFLD与肝癌发生,是潜在治疗靶点。
要点
- AATF在小鼠NASH-HCC模型及人NASH、HCC组织和多种HCC细胞系中过表达。
- TNFα通过SREBP-1c结合AATF启动子诱导AATF表达。
- AATF与STAT3相互作用上调MCP-1,敲低AATF抑制HCC细胞恶性表型及小鼠成瘤转移。
核心结论
- AATF驱动NAFLD与肝癌发生,是潜在的治疗干预靶点。
研究设计与样本
- 研究采用小鼠NASH模型(不添加特定致癌物即发生HCC)及人NASH、HCC组织与多种人HCC细胞系进行机制探索。
主要发现
- 在可发生HCC的小鼠NASH模型中初始鉴定出AATF与HCC相关。
- 人NASH与HCC组织及多种人HCC细胞系中进一步验证AATF过表达。
- NASH中升高的TNFα可诱导AATF表达。
- AATF启动子含SREBP-1c结合位点,用特异性抑制剂及小干扰RNA抑制SREBP-1可降低TNFα诱导的AATF表达。
- AATF与STAT3相互作用增加MCP-1表达;敲低AATF降低HCC细胞增殖、迁移、侵袭、集落形成及锚定依赖生长。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is increasing as a cause of liver-related mortality largely because of the growing burden of nonalcoholic steatohepatitis (NASH). The mechanisms of HCC development in nonalcoholic fatty liver disease (NAFLD) are incompletely understood. We initially identified apoptosis antagonizing transcription factor (AATF) to be associated with HCC in a mouse model of NASH that develops HCC without the addition of specific carcinogens. AATF, also called che-1, is a transcriptional factor that is highly conserved among eukaryotes. AATF is known to be a central mediator of the cellular responses as it promotes cell proliferation and survival by inducing cell cycle arrest, autophagy, DNA repair, and inhibition of apoptosis. However, the role of AATF in NASH and HCC remains unknown. Here, we provide evidence for AATF as a contributory factor for HCC in NAFLD. AATF overexpression was further verified in human NASH and HCC and multiple human HCC cell lines. Tumor necrosis factor-α (TNFα), known to be increased in NASH, induced AATF expression. Promoter analysis of AATF revealed a sterol regulatory element binding transcription factor 1-c (SREBP-1c) binding site; inhibition of SREBP-1 by using specific inhibitors as well as small interfering RNA decreased TNFα-induced AATF expression. AATF interacted with signal transducer and activator of transcription 3 to increase monocyte chemoattractant protein-1 expression. AATF knockdown decreased cell proliferation, migration, invasion, colony formation, and anchorage-dependent growth in HCC cell lines. Xenograft of QGY-7703 HCC cells with AATF stably knocked down into nonobese diabetic scid gamma mice demonstrated reduced tumorigenesis and metastases. Conclusion: AATF drives NAFLD and hepatocarcinogenesis, offering a potential target for therapeutic intervention.
引用
- Kumar DP, Santhekadur PK, Seneshaw M, et al. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30394550. doi:10.1002/hep.30346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。